U.S. prescription drug spending grew 13.1 percent last year, the highest increase in a decade, Express Scripts said Tuesday.
The spike in drug prices was primarily driven by new hepatitis C therapies with high price tags and the "exploitation of loopholes" for compounded medications, the prescription benefits manager said.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.